Spero Therapeutics Inc (SPRO) Stock Price, Quote, News & History

SPRONASDAQ
$1.23
-0.02-1.6%
At close: Sep 25, 5:00 PM EST
$1.22
-0.01-0.81%
After Hours: 7:14 PM EST

Spero Therapeutics (SPRO) Stock Price, Quote, News & History | Benzinga

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
19.58M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
-
Free Cash Flow (TTM)
19.58M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
19.58M

Analyst Trends and Forecast

1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.0
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$24.06M
PE Ratio (TTM)
8.93
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.75
PB Ratio (TTM)
1.65
Earnings Yield % (TTM)
11.20%
Earnings Yield % (FWD)
-70.40%
EV / EBITDA (TTM)
3.64
Price / EBITDA (TTM)
11.34
Price / Free Cash Flow (TTM)
3.83
Book Value / Share
$0.76

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$50.77M
Debt to Equity
0.05
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.27
Close
$1.23
Volume / Avg.
542.77K / 1.22M
Day Range
$1.21 - $1.29
52 Wk Range
1.08 - 3.08
Market Cap
$71.05M
P/E Ratio
8.93
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
2.02%
Days to Cover
3.06

About

Sector
Health Care
Industry
Biotechnology
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, teb...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Spero Therapeutics (SPRO) stock?

A

You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Spero Therapeutics (SPRO) competitors?

Q

What is the forecast, or price target, for Spero Therapeutics (SPRO) stock?

A

Spero Therapeutics has a consensus price target of $5.50.

Q

What is the current price for Spero Therapeutics (SPRO)?

A

The stock price for Spero Therapeutics (NASDAQ: SPRO) is $1.22 last updated September 25, 2026 at 7:14 PM EDT.

Q

Does Spero Therapeutics (SPRO) pay a dividend?

A

There are no upcoming dividends for Spero Therapeutics.

Q

When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?

A

Spero Therapeutics does not have any upcoming earnings scheduled.

Q

Is Spero Therapeutics (SPRO) going to split?

A

There is no upcoming split for Spero Therapeutics.

Q

What sector and industry does Spero Therapeutics (SPRO) operate in?

A

Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.